Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 35
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Met Ions Life Sci ; 16: 459-83, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26860309

RESUMEN

As a physiological phenomenon, acid secretion from the stomach was known already at least in the 17th century. But its mechanism was elucidated in more recent times only. At the end of the 20th century, gastric H(+)/K(+)-ATPase in the parietal cells was found to be responsible for a final step of H(+) secretion in these cells. In this century, several Cl(-)-transporting proteins for gastric acid (hydrochloric acid; HCl) secretion have been found. As inhibitors of gastric acid secretion, histamine H2 receptor antagonists (H2 blockers) were developed in the 1970's. This discovery brought a great benefit; that is, peptic ulcers became treatable by administration of a drug. In 1980's, proton pump inhibitors (PPIs) were developed. The target of PPIs is gastric H(+)/K(+)-ATPase and the PPIs exert generally more potent effects compared with H2 blockers. Most recently, several K(+)-competitive inhibitors of the ATPase are being developed. Here, we introduce gastric H(+)/K(+)-ATPase and its related proteins for gastric acid secretion, and several gastric diseases and their treatment by medicines.


Asunto(s)
Enfermedades Gastrointestinales/tratamiento farmacológico , Enfermedades Gastrointestinales/enzimología , ATPasa Intercambiadora de Hidrógeno-Potásio/metabolismo , Inhibidores de la Bomba de Protones/uso terapéutico , Animales , Mucosa Gástrica/metabolismo , Regulación Enzimológica de la Expresión Génica/efectos de los fármacos , Regulación Enzimológica de la Expresión Génica/fisiología , ATPasa Intercambiadora de Hidrógeno-Potásio/genética , Humanos , Transporte Iónico , Modelos Moleculares , Estructura Molecular , Conformación Proteica , Inhibidores de la Bomba de Protones/farmacología , Estómago/enzimología
2.
Eur J Pharmacol ; 765: 34-41, 2015 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-26277321

RESUMEN

4-(2-Butyl-6,7-dichloro-2-cyclopentylindan-1-on-5-yl)oxybutyric acid (DCPIB) has been used as an inhibitor of volume-regulated anion channel (VRAC), which is expressed in almost all cells (IC50 is around 4 µM). Here, we found that DCPIB significantly inhibited the activities of gastric proton pump (H+,K+-ATPase) in isolated gastric tubulovesicles and the membrane sample of the H+,K+-ATPase-expressing cells, and their IC50 values were around 9 µM. In the tubulovesicles, no significant expression of leucine rich repeat containing 8 family member A (LRRC8A), an essential component of VRAC, was observed. The inhibitory effect of DCPIB was also found in the membrane sample obtained from the cells in which LRRC8A had been knocked down. On the other hand, DCPIB had no significant effect on the activity of Na+,K+-ATPase or Ca2+-ATPase. In the H+,K+-ATPase-expressing cells, DCPIB inhibited the 86Rb+ transport activity of H+,K+-ATPase but not that of Na+,K+-ATPase. DCPIB had no effect on the activity of Cl- channels other than VRAC in the cells. These results suggest that DCPIB directly inhibits H+,K+-ATPase activity. DCPIB may be a beneficial tool for studying the H+,K+-ATPase function in vitro.


Asunto(s)
Ciclopentanos/farmacología , Mucosa Gástrica/metabolismo , ATPasa Intercambiadora de Hidrógeno-Potásio/metabolismo , Indanos/farmacología , Proteínas de la Membrana/antagonistas & inhibidores , Proteínas de la Membrana/metabolismo , Inhibidores de la Bomba de Protones/farmacología , Animales , Relación Dosis-Respuesta a Droga , Mucosa Gástrica/efectos de los fármacos , Células HEK293 , Humanos , Transporte Iónico/efectos de los fármacos , Transporte Iónico/fisiología , Células LLC-PK1 , Porcinos
3.
Biochem Biophys Res Commun ; 424(1): 136-40, 2012 Jul 20.
Artículo en Inglés | MEDLINE | ID: mdl-22732406

RESUMEN

K(+)-Cl(-) cotransporter-3a (KCC3a) is associated with Na(+),K(+)-ATPase α1-subunit (α1NaK) in lipid rafts of gastric acid-secreting cells and positively regulates Na(+),K(+)-ATPase activity. Here, effects of cholesterol on association of KCC3a with α1NaK in lipid rafts were studied in LLC-PK1 cells stably expressing KCC3a. In the cells, lipid rafts destructed by methyl-ß-cyclodextrin (MßCD) could be reconstructed by exogenous addition of cholesterol accompanying a shift of both KCC3a and α1NaK from non-rafts to rafts. The KCC3a-increased Na(+),K(+)-ATPase activity was abolished by MßCD, and recovered by repletion of cholesterol without changing expression levels of KCC3a and α1NaK in the cells. KCC3a was co-immunoprecipitated with α1NaK even after destruction of lipid rafts by MßCD, indicating that molecular association of KCC3a with α1NaK still retains in the non-raft environment. Our results suggest that cholesterol is essential for eliciting up-regulation of Na(+),K(+)-ATPase activity by KCC3a in the KCC3a-α1NaK complex.


Asunto(s)
Colesterol/metabolismo , Microdominios de Membrana/metabolismo , ATPasa Intercambiadora de Sodio-Potasio/metabolismo , Simportadores/metabolismo , Animales , Línea Celular , Colesterol/farmacología , Ratas , Porcinos , Simportadores/antagonistas & inhibidores , Simportadores/genética , beta-Ciclodextrinas/farmacología
4.
J Physiol Sci ; 62(1): 53-8, 2012 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-21932081

RESUMEN

Effects of curcumin, a major constituent of turmeric, on ecto-nucleotidases have not been clarified. Here, we investigated whether curcumin affects ecto-nucleotidase activities in human hepatocellular carcinoma HepG2 cells. In the cells, high levels of Mg(2+)-dependent activity of ecto-nucleotidases were observed in the presence of 1 mM adenosine triphosphate (ATP). The activity was inhibited by ecto-ATPase inhibitors such as suramin, ZnCl(2) and 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid. On the other hand, the activity was significantly decreased at alkaline pH (pH 9) and was not inhibited by levamisole, an inhibitor of alkaline phosphatase. In the presence of ATP, curcumin inhibited the activity in a concentration-dependent manner (IC(50) = 6.2 µM). In contrast, curcumin had no effects on ecto-nucleotidase activity in the presence of ADP (1 mM) or AMP (1 mM). The K (m) value for ATP hydrolysis of curcumin-sensitive ecto-ATPase was similar to the value of NTPDase2, an isoform of ecto-nucleoside triphosphate diphosphohydrolase. These results suggest that curcumin is a potent inhibitor of ecto-ATPase and may affect extracellular ATP-dependent responses.


Asunto(s)
Adenosina Trifosfatasas/antagonistas & inhibidores , Curcumina/farmacología , Ácido 4,4'-Diisotiocianostilbeno-2,2'-Disulfónico/farmacología , Cloruros/farmacología , Células Hep G2 , Humanos , Cinética , Magnesio/farmacología , Suramina/farmacología , Compuestos de Zinc/farmacología
6.
Biol Pharm Bull ; 34(6): 810-2, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21628876

RESUMEN

Gastric proton pump (H⁺, K⁺-ATPase) secretes H⁺ of acid (HCl) via the luminal membrane of parietal cells. For the HCl secretion, Cl⁻- and K⁺-transporting proteins are required. Recent our studies have demonstrated that K⁺-Cl⁻ cotransporters (KCC3a and KCC4) are expressed in gastric parietal cells. KCC3a is associated with Na⁺, K⁺-ATPase in the basolateral membrane, and KCC4 is associated with H⁺, K⁺-ATPase in the apical canalicular membrane. This paper summarizes the functional association between KCCs and P-type ATPases and the contribution of these complexes to acid secretion in gastric parietal cells.


Asunto(s)
Ácido Gástrico/metabolismo , Células Parietales Gástricas/metabolismo , Vías Secretoras , Simportadores/metabolismo , Animales , Polaridad Celular , Humanos , Microdominios de Membrana/metabolismo , Isoformas de Proteínas/metabolismo , Bombas de Protones/metabolismo , ATPasa Intercambiadora de Sodio-Potasio/metabolismo
7.
Biochem Biophys Res Commun ; 399(4): 683-7, 2010 Sep 03.
Artículo en Inglés | MEDLINE | ID: mdl-20691666

RESUMEN

K(+)-Cl(-) cotransporter-3 has two major amino terminal variants, KCC3a and KCC3b. In LLC-PK1 cells, exogenously expressed KCC3a co-immunoprecipitated with endogenous Na(+),K(+)-ATPase alpha1-subunit (alpha1NaK), accompanying significant increases of the Na(+),K(+)-ATPase activity. Exogenously expressed KCC3b did not co-immunoprecipitate with endogenous alpha1NaK inducing no change of the Na(+),K(+)-ATPase activity. A KCC inhibitor attenuated the Na(+),K(+)-ATPase activity in rat gastric mucosa in which KCC3a is predominantly expressed, while it had no effects on the Na(+),K(+)-ATPase activity in rat kidney in which KCC3b is predominantly expressed. In these tissue samples, KCC3a co-immunoprecipitated with alpha1NaK, while KCC3b did not. Our results suggest that the NH(2)-terminus of KCC3a is a key region for association with alpha1NaK, and that KCC3a but not KCC3b can regulate the Na(+),K(+)-ATPase activity.


Asunto(s)
ATPasa Intercambiadora de Sodio-Potasio/metabolismo , Simportadores/metabolismo , Animales , Línea Celular , Mucosa Gástrica/metabolismo , Inmunoprecipitación , Riñón/metabolismo , Estructura Terciaria de Proteína , Ratas , Simportadores/genética , Tetraciclina/farmacología , Regulación hacia Arriba
9.
J Physiol Sci ; 59(2): 113-22, 2009 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-19340551

RESUMEN

Litttle is known about the function of aquaporin (AQP) water channels in human gastric cancer. In the upper or middle part of human stomach, we found that expression level of AQP5 protein in intestinal type of adenocarcinoma was significantly higher than that in accompanying normal mucosa. AQP5 was localized in the apical membrane of the cancer cells. On the other hand, both AQP3 and AQP4 were not up-regulated in the adenocarcinoma. To elucidate the role of AQP5 in cancer cells, AQP5 was exogenously expressed in a cell line of poorly differentiated human gastric adenocarcinoma (MKN45). The AQP5 expression significantly increased the proportion of differentiated cells with a spindle shape, the activity of alkaline phosphatase, a marker for the intestinal epithelial cell type of cancer cells, and the expression level of laminin, an epithelial cell marker. Treatment of the MKN45 cells stably expressing AQP5 with HgCl(2), an inhibitor of aquaporins, significantly decreased the proportion of differentiated cells and the activity of alkaline phosphatase. Our results suggest that up-regulation of AQP5 may be involved in differentiation of human gastric cancer cells.


Asunto(s)
Adenocarcinoma/metabolismo , Adenocarcinoma/patología , Acuaporina 5/metabolismo , Diferenciación Celular/fisiología , Neoplasias Gástricas/metabolismo , Neoplasias Gástricas/patología , Anciano , Anciano de 80 o más Años , Fosfatasa Alcalina/metabolismo , Acuaporina 5/antagonistas & inhibidores , Biomarcadores/metabolismo , Línea Celular Tumoral , Femenino , Humanos , Laminina/metabolismo , Masculino , Cloruro de Mercurio/farmacología , Persona de Mediana Edad
10.
J Biol Chem ; 284(1): 619-629, 2009 Jan 02.
Artículo en Inglés | MEDLINE | ID: mdl-18984587

RESUMEN

We studied whether K+-Cl(-) cotransporters (KCCs) are involved in gastric HCl secretion. We found that KCC4 is expressed in the gastric parietal cells more abundantly at the luminal region of the gland than at the basal region. KCC4 was found in the stimulation-associated vesicles (SAV) derived from the apical canalicular membrane but not in the intracellular tubulovesicles, whereas H+,K+-ATPase was expressed in both of them. In contrast, KCC1, KCC2, and KCC3 were not found in either SAV or tubulovesicles. KCC4 coimmunoprecipitated with H+,K+-ATPase in the lysate of SAV. Interestingly the MgATP-dependent uptake of (36)Cl(-) into the SAV was suppressed by either the H+,K+-ATPase inhibitor (SCH28080) or the KCC inhibitor ((R)-(+)-[(2-n-butyl-6,7-dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1H-inden-5-yl)oxy]acetic acid). The KCC inhibitor suppressed the H+ uptake into SAV and the H+,K+-ATPase activity of SAV, but the inhibitor had no effects on these activities in the freeze-dried leaky SAV. These results indicate that the K+-Cl(-) cotransport by KCC4 is tightly coupled with H+/K+ antiport by H+,K+-ATPase, resulting in HCl accumulation in SAV. In the tetracycline-regulated expression system of KCC4 in the HEK293 cells stably expressing gastric H+,K+-ATPase, KCC4 was coimmunoprecipitated with H+,K+-ATPase. The rate of recovery of intracellular pH in the KCC4-expressing cells after acid loading through an ammonium pulse was significantly faster than that in the KCC4-non-expressing cells. Our results suggest that KCC4 and H+,K+-ATPase are the main machineries for basal HCl secretion in the apical canalicular membrane of the resting parietal cell. They also may contribute in part to massive acid secretion in the stimulated state.


Asunto(s)
Membrana Celular/metabolismo , ATPasa Intercambiadora de Hidrógeno-Potásio/metabolismo , Células Parietales Gástricas/metabolismo , Simportadores/metabolismo , Animales , Membrana Celular/genética , Células Cultivadas , Inhibidores Enzimáticos/farmacología , ATPasa Intercambiadora de Hidrógeno-Potásio/genética , Humanos , Ácido Clorhídrico/metabolismo , Concentración de Iones de Hidrógeno , Imidazoles/farmacología , Ratones , Células Parietales Gástricas/citología , Inhibidores de la Bomba de Protones , Conejos , Ratas , Vesículas Secretoras/metabolismo , Porcinos , Simportadores/antagonistas & inhibidores
11.
J Biol Chem ; 283(24): 16876-84, 2008 Jun 13.
Artículo en Inglés | MEDLINE | ID: mdl-18403373

RESUMEN

Gastric H(+),K(+)-ATPase is shown to transport 2 mol of H(+)/mol of ATP hydrolysis in isolated hog gastric vesicles. We studied whether the H(+) transport mechanism is due to charge transfer and/or transfer of hydronium ion (H(3)O(+)). From transport of [(18)O]H(2)O, 1.8 mol of water molecule/mol of ATP hydrolysis was found to be transported. We performed a molecular dynamics simulation of the three-dimensional structure model of the H(+),K(+)-ATPase alpha-subunit at E(1) conformation. It predicts the presence of a charge transfer pathway from hydronium ion in cytosolic medium to Glu-345 in cation binding site 2 (H(3)O(+)-Lys-164 -Gln-161-Glu-345). No charge transport pathway was formed in mutant Q161L, E345L, and E345D. Alternative pathways (H(3)O(+)-Gln-161-Glu-345) in mutant K164L and (H(3)O(+)-Arg-105-Gln-161-Gln-345) in mutant E345Q were formed. The H(+),K(+)-ATPase activity in these mutants reflected the presence and absence of charge transfer pathways. We also found charge transfer from sites 2 to 1 via a water wire and a charge transfer pathway (H(3)O(+)-Asn-794 -Glu-797). These results suggest that protons are charge-transferred from the cytosolic side to H(2)O in sites 2 and 1, the H(2)O comes from cytosolic medium, and H(3)O(+) in the sites are transported into lumen during the conformational transition from E(1)PtoE(2)P.


Asunto(s)
Mucosa Gástrica/metabolismo , ATPasa Intercambiadora de Hidrógeno-Potásio/metabolismo , Protones , Adenosina Trifosfatasas/metabolismo , Animales , Sitios de Unión , Transporte Biológico , Citosol/metabolismo , Humanos , Hidrólisis , Modelos Biológicos , Mutagénesis Sitio-Dirigida , Mutación , Conformación Proteica , Porcinos
12.
J Biol Chem ; 283(11): 6869-77, 2008 Mar 14.
Artículo en Inglés | MEDLINE | ID: mdl-18178552

RESUMEN

Gastric parietal cells migrate from the luminal to the basal region of the gland, and they gradually lose acid secretory activity. So far, distribution and function of K+-Cl(-) cotransporters (KCCs) in gastric parietal cells have not been reported. We found that KCC3a but not KCC3b mRNA was highly expressed, and KCC3a protein was predominantly expressed in the basolateral membrane of rat gastric parietal cells located in the luminal region of the glands. KCC3a and the Na+,K+-ATPase alpha1-subunit (alpha1NaK) were coimmunoprecipitated, and both of them were highly localized in a lipid raft fraction. The ouabain-sensitive K+-dependent ATP-hydrolyzing activity (Na+,K+-ATPase activity) was significantly inhibited by a KCC inhibitor (R-(+)-[(2-n-butyl-6,7-dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1H-inden-5-yl)oxy]acetic acid (DIOA)). The stable exogenous expression of KCC3a in LLC-PK1 cells resulted in association of KCC3a with endogenous alpha1NaK, and it recruited alpha1NaK in lipid rafts, accompanying increases of Na+,K+-ATPase activity and ouabain-sensitive Na+ transport activity that were suppressed by DIOA, whereas the total expression level of alpha1NaK in the cells was not significantly altered. On the other hand, the expression of KCC4 induced no association with alpha1NaK. In conclusion, KCC3a forms a functional complex with alpha1NaK in the basolateral membrane of luminal parietal cells, and it up-regulates alpha1NaK in lipid rafts, whereas KCC3a is absent in basal parietal cells.


Asunto(s)
Regulación de la Expresión Génica , Células Parietales Gástricas/citología , ATPasa Intercambiadora de Sodio-Potasio/fisiología , Simportadores/fisiología , Acetatos/farmacología , Adenosina Trifosfato/metabolismo , Animales , Transporte Biológico , Humanos , Inmunoprecipitación , Indenos/farmacología , Microdominios de Membrana/metabolismo , Ratas
13.
Eur J Pharmacol ; 560(2-3): 123-6, 2007 Apr 10.
Artículo en Inglés | MEDLINE | ID: mdl-17303113

RESUMEN

[(Dihydroindenyl)oxy]acetic acid (DIOA) has been used as a potent inhibitor of K+ -Cl- cotransporter (IC(50)=10 microM). Here we found that DIOA inhibited activities of P-type ATPases such as dog kidney Na+,K+-ATPase (IC(50)=53 microM), hog gastric H+,K+-ATPase (IC(50)=97 microM) and rabbit muscle Ca(2+)-ATPase (IC(50)=127 microM). In the membrane preparation of the LLC-PK1 cells stably expressing rabbit gastric H+,K+-ATPase, DIOA inhibited activities of the endogenous Na+,K+-ATPase (IC(50)=95 microM) and the exogenous H+,K+-ATPase (IC(50)=75 microM). 5-Nitro-2-(3-phenylpropylamino)-benzoic acid (NPPB), a Cl- channel blocker, had no effects on the DIOA-elicited inhibition of the P-type ATPases. These findings suggest that lower concentration of DIOA (< 20-30 microM) should be used for evaluation of the activity of K+ -Cl- cotransporter without affecting the activities of coexisting Na+,K+ -ATPase and/or H+,K+-ATPase in cells.


Asunto(s)
Acetatos/farmacología , Inhibidores Enzimáticos/farmacología , Indenos/farmacología , Inhibidores de la Bomba de Protones , ATPasa Intercambiadora de Sodio-Potasio/antagonistas & inhibidores , Simportadores/antagonistas & inhibidores , Animales , Perros , Relación Dosis-Respuesta a Droga , Conejos , Porcinos , Cotransportadores de K Cl
14.
Cell Stress Chaperones ; 11(3): 259-67, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-17009599

RESUMEN

The effects of heat shock protein 70 (Hsp70), a molecular chaperone, on the degradation and functional alterations of a mutant large T antigen induced by a nonpermissive temperature were examined. In this study, mouse tracheal epithelial TM02-3 cells harboring temperature-sensitive simian virus 40 large T antigen and stable TM02-3 cells overexpressing human Hsp70 and/or Hsp40 were used. Although the temperature shift from 33 degrees C (permissive temperature) to 39 degrees C (nonpermissive temperature) induced increases in the endogenous chaperones including Hsp70 and Hsp40, degradation of the T antigen, activation of the p53-p21(waf1) pathway, and an arrest of cell growth were observed in the mock cells. In contrast, these changes induced by the temperature shift were partially but significantly prevented in stable cells overexpressing human Hsp70 and/or Hsp40. A combination of Hsp70 and Hsp40 was the most effective, suggesting that Hsp40 may cooperate with Hsp70. Moreover, immunocytochemical observation indicated that human Hsp70 was expressed in the cytoplasm at 33 degrees C, but it colocalized with T antigen in the nucleus at 39 degrees C. These results suggest that overexpressed Hsp70 translocates from the cytoplasm to nucleus, and significantly restores the structural stability and functional defects of mutant large T antigen in the cells.


Asunto(s)
Antígenos Virales de Tumores/genética , Proteínas HSP70 de Choque Térmico/metabolismo , Mutación , Virus 40 de los Simios/inmunología , Temperatura , Animales , Recuento de Células , Línea Celular , Núcleo Celular/metabolismo , Citoplasma/metabolismo , Proteínas del Choque Térmico HSP40/metabolismo , Humanos , Inmunohistoquímica , Ratones , Ratones Transgénicos , Conformación Proteica , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Tráquea/citología , Tráquea/metabolismo
15.
FEBS Lett ; 580(14): 3368-74, 2006 Jun 12.
Artículo en Inglés | MEDLINE | ID: mdl-16709411

RESUMEN

Tumor growth of colorectal cancers accompanies upregulation of cyclooxygenase-2, which catalyzes a conversion step from arachidonic acid to prostaglandin H(2) (PGH(2)). Here, we compared the expression levels of thromboxane synthase (TXS), which catalyzes the conversion of PGH(2) to thromboxane A(2) (TXA(2)), between human colorectal cancer tissue and its accompanying normal mucosa. It was found that TXS protein was consistently upregulated in the cancer tissues from different patients. TXS was also highly expressed in human colonic cancer cell lines. Depletion of TXS protein by the antisense oligonucleotide inhibited proliferation of the cancer cells. This inhibition was rescued by the direct addition of a stable analogue of TXA(2). The present results suggest that overexpression of TXS and subsequent excess production of TXA(2) in the cancer cells may be involved in the tumor growth of human colorectum.


Asunto(s)
Proliferación Celular/efectos de los fármacos , Neoplasias Colorrectales/enzimología , Tromboxano A2/farmacología , Tromboxano-A Sintasa/metabolismo , Regulación hacia Arriba/efectos de los fármacos , Western Blotting , Línea Celular Tumoral , Neoplasias Colorrectales/patología , Humanos , Inmunohistoquímica , Oligonucleótidos/farmacología
16.
J Physiol ; 562(Pt 3): 885-97, 2005 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-15611029

RESUMEN

Increased release of thromboxane A(2) (TXA(2)) has been shown to be involved in inflammatory bowel diseases. In the present study, we have investigated the effect of a stable TXA(2) analogue (STA(2)) on the electrical parameters in isolated human colonic mucosa. In the human mucosa set between Ussing chambers, STA(2) stimulated Cl- secretion in a concentration-dependent manner with an EC(50) of 0.06 microm. The STA(2)-induced Cl- secretion was significantly inhibited by ONO-3708 (10 microm), a specific TXA(2) receptor antagonist. The effect of STA(2) (0.3 microm) was independent of the colonic segment from which the tissue was obtained, from caecum to rectum. Chromanol 293B, an inhibitor of the cAMP-dependent KvLQT1 channel, attenuated the STA(2)-induced Cl- secretion in the human colonic mucosa (IC(50) value 1.18 microm). We found that KvLQT1 mRNA and protein were expressed in all the tested segments of the human colon. The STA(2)-induced Cl- secretion was significantly inhibited by 8-bromo-2'-monobutyryladenosine-3',5'-cyclic monophosphorothioate (50 microm), a membrane-permeant cAMP antagonist. STA(2) (0.3 microm) significantly increased the intracellular cAMP levels and the short-circuit current via TXA(2) receptor in a human colonic cell line. These results suggest that the TXA(2)-induced Cl- secretion in the colon is mediated via the cAMP pathway in addition to the Ca(2+)-calmodulin pathway which was previously reported.


Asunto(s)
Cloro/metabolismo , Colon/metabolismo , AMP Cíclico/metabolismo , Mucosa Intestinal/metabolismo , Tromboxano A2/farmacología , Anciano , Animales , Colon/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Femenino , Humanos , Técnicas In Vitro , Mucosa Intestinal/efectos de los fármacos , Masculino , Persona de Mediana Edad , Ratas , Ratas Wistar , Transducción de Señal/efectos de los fármacos , Especificidad de la Especie
17.
FEBS Lett ; 575(1-3): 105-8, 2004 Sep 24.
Artículo en Inglés | MEDLINE | ID: mdl-15388342

RESUMEN

It has been controversial whether the ClC-2 chloride channel is involved in hydrochloric acid secretion of gastric parietal cells. Here, we investigated whether ClC-2 is the apical Cl- channel associated with gastric acid secretion. Two anti-ClC-2 antibodies used in this study reacted with cloned ClC-2 protein expressed in HEK293 cells. In isolated rabbit gastric glands, significant expression of ClC-2 mRNA was observed, but the presence of ClC-2 protein was not clear. Furthermore, no expression of ClC-2 protein was observed in isolated rat and human gastric mucosa. Immunohistochemistry on the rat gastric mucosa showed no significant expression of ClC-2 protein in the parietal cells which showed abundant expression of H+,K+-ATPase. These results indicate that ClC-2 may not be a Cl- -transporting protein for gastric acid secretion in parietal cells.


Asunto(s)
Canales de Cloruro/metabolismo , Cloruros/metabolismo , Ácido Gástrico/metabolismo , Células Parietales Gástricas/metabolismo , Anciano , Animales , Canales de Cloruro CLC-2 , Línea Celular , Canales de Cloruro/genética , Femenino , Mucosa Gástrica/citología , Mucosa Gástrica/metabolismo , ATPasa Intercambiadora de Hidrógeno-Potásio/genética , ATPasa Intercambiadora de Hidrógeno-Potásio/metabolismo , Humanos , Masculino , Persona de Mediana Edad , Células Parietales Gástricas/citología , ARN Mensajero/metabolismo , Conejos , Ratas , Estómago/anatomía & histología
18.
FEBS Lett ; 563(1-3): 151-4, 2004 Apr 09.
Artículo en Inglés | MEDLINE | ID: mdl-15063740

RESUMEN

We investigated expression levels of Na(+),K(+)-ATPase alpha-isoforms and their ATPase activities in human colorectal cancer tissue and the accompanying normal mucosa. A decrease in expression of the alpha1-isoform protein was observed in all sampled cancer tissues compared with the normal mucosae. The level of ouabain (5 microM)-sensitive Na(+),K(+)-ATPase activity in carcinomas was 81+/-5% that of in the normal mucosae. The mRNA expression of alpha2- and alpha 4-isoforms was decreased in almost all the carcinoma samples. Interestingly, the expression level of the alpha 3-isoform protein in the cancer tissue was higher than that of the normal mucosa. These results indicate that a decrease in the alpha1-isoform expression and an increase in the alpha 3-isoform expression may be associated with colorectal cancer.


Asunto(s)
Carcinoma/genética , Neoplasias del Colon/genética , Regulación hacia Abajo , ATPasa Intercambiadora de Sodio-Potasio/metabolismo , Regulación hacia Arriba , Pueblo Asiatico , Carcinoma/metabolismo , Línea Celular Tumoral , Neoplasias del Colon/metabolismo , Femenino , Expresión Génica , Regulación Enzimológica de la Expresión Génica/efectos de los fármacos , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Humanos , Isoenzimas/genética , Isoenzimas/metabolismo , Masculino , Ouabaína/metabolismo , ARN Mensajero/metabolismo , ATPasa Intercambiadora de Sodio-Potasio/genética
19.
Jpn J Physiol ; 54(1): 71-7, 2004 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-15040851

RESUMEN

Sargassum horneri is an edible marine brown alga distributed along the seacoast of Japan. Here we examined effects on the water-soluble (ethanol-insoluble) extracts (EIS) from Sargassum horneri on ion transports across the isolated rat colonic mucosa set in Ussing chambers. The nonpolysaccharide fraction of EIS (EIS-2) significantly decreased short-circuit current (Isc) across the mucosa, and increased the tissue conductance (Gt). The half-maximal effect of EIS-2 was obtained at 20 microg/ml. In contrast, the polysaccharide fraction of EIS (EIS-1; 100 microg/ml) had little effect on Isc and Gt. The effect of EIS-2 depended on the presence of Cl- and HCO3- but not K+ in the bathing solution. These results suggest that EIS-2 stimulates Cl)absorption in the colonic mucosa. The EIS-2-induced changes in Isc and Gt were inhibited by 3-(1-[p-chlorobenzyl]-5-[isopropyl]-3-t-butylthioindol-2-yl)-2,2-dimethyl-propanoic acid sodium (MK-886; 10 microM), a 5-lipoxygenase-activating protein inhibitor, and 5-nitro-2-(3-phenylpropylamino)-benzoate (NPPB; 100 microM), a Cl- channel blocker. EIS-2 attenuated the prostaglandin E2 (0.5 microM)-increased Isc, and the half-maximal effect of EIS-2 was obtained at 50 microg/ml. The present study suggests that the EIS-2 stimulates Cl- absorption mediated by basolateral leukotriene-sensitive Cl- channels and apical Cl-/HCO3- exchanger in the rat colonic mucosa.


Asunto(s)
Extractos Celulares/farmacología , Canales de Cloruro/fisiología , Cloro/farmacocinética , Colon Descendente/efectos de los fármacos , Colon Descendente/fisiología , Leucotrienos/farmacología , Sargassum/química , Absorción , Animales , Permeabilidad de la Membrana Celular/efectos de los fármacos , Permeabilidad de la Membrana Celular/fisiología , Canales de Cloruro/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Femenino , Ratas , Ratas Sprague-Dawley , Técnicas de Cultivo de Tejidos , Agua/química
20.
Biol Pharm Bull ; 27(1): 1-12, 2004 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-14743830

RESUMEN

The gastric H+, K+-ATPase is a proton pump that is responsible for gastric acid secretion and that actively transports protons and K+ ions in opposite directions to generate in excess of a million-fold gradient across the membrane under physiological conditions. This pump is also a target molecule of proton pump inhibitors which are used for the clinical treatment of hyperacidity. In this review, we wish to summarize the molecular regulation of this pump based on mutational studies, particularly those used for the identification of binding sites for cations and specific inhibitors. Recent reports by Toyoshima et al (2000, 2002) presented precise three-dimensional (3-D) structures of the sarcoplasmic reticulum (SR) Ca2+-ATPase, which belongs to the same family as the gastric H+, K+-ATPase. We have studied the structure-function relationships for the gastric H+, K+-ATPase using 3-D structures constructed by homology modeling of the related SR Ca2+-ATPase, which was used as a template molecule. We also discuss in this review, the regulation of cell surface expression and synthesis control of the gastric proton pump.


Asunto(s)
Mucosa Gástrica/química , Mucosa Gástrica/enzimología , Bombas de Protones/fisiología , Animales , Retículo Endoplásmico/enzimología , Inhibidores Enzimáticos/farmacología , ATPasa Intercambiadora de Hidrógeno-Potásio/biosíntesis , ATPasa Intercambiadora de Hidrógeno-Potásio/metabolismo , Humanos , Modelos Moleculares , Conformación Proteica , Inhibidores de la Bomba de Protones , Bombas de Protones/biosíntesis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...